Weiser, T., Schepers, C., Mück, T., & Lange, R. (2019). Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers. Clin Pharmacol Drug Dev.
Citação norma ChicagoWeiser, Thomas, Cornelia Schepers, Tobias Mück, and Robert Lange. "Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU As Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers." Clin Pharmacol Drug Dev 2019.
MLA citiranjeWeiser, Thomas, Cornelia Schepers, Tobias Mück, and Robert Lange. "Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU As Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers." Clin Pharmacol Drug Dev 2019.